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Abstract 
The present study was carried out to evaluate the effective role of PON and Il- 35 in serum female patients  with 
multiple sclerosis (MS). In this study , 30 females were enrolled , the duration of the disease was from 3 months 
to 2 years (Group2 G2) were taken from Baghdad teaching hospital through the period from April-2013 to – 
Dec.2013. They were compared with 30 apparently healthy females with the same range of age (20 to 30) years 
(Group 1 G1) .Results Showed high significant decrease of PON in Group 2 compared with Group 1 , while high 
significant increase in IL- 35 was noted in Group 2 compared with Group 1 .Besides , high significant positive 
Correlation was observed between PON and IL- 35 in both of Group 1 and Group 2. It was conclude that PON 
and IL -35 may be used as a clinical marker In Multiple Sclerosis disease. 
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1.0  Introductio 
Multiple Sclerosis (MS) is a chronic disorder, of the central nervous system (CNS). 
Characterized by autoimmune in flammation , demyelination ,and axonal damage.[ Rossalind et al., 
2012 ] and [ Manual et al., 2012 ] 
This disease is also Known as " disseminated sclerosis "or" encephalomyelitis .disseminata which is an 
in flammatory disease in which the fatty myelin sheath around the axons of the brain spinal cord are damaged, 
leading to demyelination and scarring as well a broad of signs and symptoms. [Compston et al, 2008]. 
The three signs of MS now Known as Charcots , triad are nystagmus , intention tremor , and 
impediment speech (scanning speech). [ Clanet ., 2008].  
Lethal autoimmune disease can be developed in the absence of effective immune suppressive mediators. 
Regulatory T cells (Treg cells) are necessary for immune homeostasis and to prevent outoimmunity , 
yet they are also antitumor immunity. [ Vignali et al., 2008] Treg cells use a broad range of mechanisms to 
suppress immunity , including suppressive cytokine such as IL- 35. IL35 is distinct from other family members 
in that it is produced by Treg cell populations and it is  suppressive. In vitro and in vivo , IL- 35 has two Known 
biological effects: 
Supression of the proliferative of conventional T cells , and the conversion of native T cells into a 
strongly suppressive induced Treg cell population , called (iTr 35) cells which function in via IL -35. [ Lauren et 
al., 2010]. 
On the other hand , reactive oxygen species (ROS) and subsequnt oxidative damage may contribute to 
the formation and persistence of multiple sclerosis (MS) lesions by acting on distinct pathological processes. 
Oxidative stress can be counteracted by endogenous antioxidant enzymes that confer protection against oxidative 
damage such as paraoxonase (PON). [ Horssen et al., 2008]  
PON , is an enzyme that protects low density lipoprotein from oxidative modification [ Whitehead  et . 
al, 2011]. 
 
2.0 Materials and Methods 
2.1 Subjects 
Thirty (30) females of age (20-30) years were enrolled in this study , who attended Baghdad Teaching Hospital 
and diagnosed by physicians as Multiple sclerosis patients , they were compared with (30) apparently healthy 
females in the same range of age. 
 
2.2 Blood Sampling and Parameter Determination :-  
Five Milliliters (5 mL) of venous blood were collected from all subjects enrolled in this study , placed in to plain 
tubes until coagulation was performed. Serum was separated from blood cells by centrifugation 4000 r.p.m. The 
quantitive sandwich enzyme immunoassay (ELISA) technique was employed for the determination of PON and 
IL -35. 
 
2.3 Statistical Analysis  
Student t-test was applied to compare the significance of the difference in the mean values of control and patient 
groups. (p<0.001)was considered high significance. 
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The correlation coefficient (r) test was used for describing the association between parameters. Standard 
Error of Mean (SEM) is the standard deviation of the sample mean estimate of population mean. 
 
3.0 Results 
Our results have shown that PON activity had a high significant decrease (p<0.001) in sera of Group 2 (784.32 ± 
21.8) mL U/ml compared with Group 1(1106 . 552 ± 22.6 ) mLU/mL.As well, high significant increase (p<0.001) 
was found in sera of Group 2 (39.14 ± 1.4) pg /ml compared with Group 1 (29.3 ± 1.3) pg /ml. 
In addition , high significant positive correlation was observed between PON and IL- 35 in both of 
Group 1 and Group2. 
 
4.0 Discussion 
Interlenkin – 35 (IL – 35) has been reported to show the recently discovered inhibitory cytokine that is produces 
by foxp 3 + regulatory T cells (Tregs)and contributes to their suppressive function in autoimmune diseases. 
[ Mattson et al., 1995]. 
Interleukin – 35 (IL-35) is distinct from other Family member since that it is produced by treg cell 
populations and it is suppressive. In vitro and in vivo, IL -35 has three Known biological effects: 
Suppression of T Cell proliferation , the conversion of naive T cells in to IL-35 , Producing induced 
regulatory T cells (iTr 35 Cells) , down regulation of the 17 cell development , differentiation and suppression of 
autoimmune inflammtion.[Vignali et al., 2012], [ Collision et al., 2009] , [ Collison et al., 2008] , [ Kochet Kova 
et al., 2010] , [ Bardel et al., 2008] , [ Bettimi et al., 2009] , [ collision et al, 2012] , [ Wirtz et al, 2011] and 
[ Xinyuan et al., 2012]. 
Recent studies have revealed the role of IL -35 in regulating immunologic  responses through induction 
of inducible IL- 35 producing Treg Cells. Interlukin–35 (IL-35) suppresses T effector (T eff) functions such as 
Th 1 and Th 17 , on other hand activate Th 2 that change immune  responses and so called immunomodulation 
process in body. [ chung et al., 2012] and [Astry et al., 2011]. 
Broadly , Paraoxonase (PON) is an enzyme that protects low density lipoprotein from oxidative 
modification. ROS initiate lesions formation of multiple sclerosis by inducing blood – brain barrier disruption , 
enhance leukocyte migration and myelin phagocytosis , and contribute to lesion persistence by mediating cellular 
damage to essential biological macromolecules of vulnerable CNS Cells. [ Whithead et al., 2011] and [ Horssen 
et al, 2008]. 
A previous study have suggested a role of the oxidative stress and lipid peroxidation in the 
inflammatory processes and in the pathogensis of multiple sclerosis (MS) , a degenerative inflammatory disease 
of the central nervous system (CNS) characterized by autoimmune attack to myelin antigens, reactive Oxygen 
species (ROS) generated in excess primarily by macorophages, have been implicated as mediators of 
demyelination and axonal damage , as a result , antioxidant enzymes shch as PON is lower in plasma of MS 
patients with respect to healthy subjects [ Ferretti et al,m 2005]. 
Table 1 :- Level of pataoxonase (PON) and Interleukin –35(IL-35) in the sera of studied groups . 
Parameter Mean ± SEM/ G1 Mean ± /SEM / G2 T.Test 
PON 1106.552/±22.6   
mL U / mL 
784.32 ± 21.8  
mL U / mL  
H.S 
IL-35 29.3± 1.3 pg / mL 39.14 ± 1.4 pg / mL H.S 
G1:- Health control Group  
G2- Multiple Sclerosis patient group. 
SEM: Standard error mean. 
H.S :- High significant variation (p<0.001)  
 
Table 2:- Corretation between PON and IL-35 
Correlation Group 1 (G1) Group 2(G2) 
PON  
and  
IL- 35 
r 0.0779 0.3839 
P P<0.001 P<0.001 
r:- Correlation Coefficient  test   
P:- Probability (student t. test ) 
*  There were high significant positive correlation between PON and IL- 35 (r=0.0779 , p<0.001 ) in Group 1 
(G1) and (r= 0.3839, p<0.001) in Group2 (G2) as seen in fig 1  
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Fig 1:- Correelation between Pon and Il-35 
 
5.0 Conclusion  
It was concluded that Paroxanase and Interleukin-35, may be used as a novel clinical marker in multiple sclerosis 
(MS) diseases. 
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